Followers | 259 |
Posts | 51078 |
Boards Moderated | 18 |
Alias Born | 08/29/2007 |
![](https://investorshub.advfn.com/uicon/108458.png?cb=1482855649)
Sunday, May 05, 2024 10:43:11 AM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent ELTX News
- Elicio Therapeutics Reports Inducement Grants • GlobeNewswire Inc. • 06/18/2024 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/12/2024 04:15:14 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/03/2024 09:24:20 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 06/03/2024 08:41:17 PM
- Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting • GlobeNewswire Inc. • 05/23/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:34:02 PM
- Elicio Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 05/15/2024 08:30:00 PM
- Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting • GlobeNewswire Inc. • 04/25/2024 12:30:00 PM
- Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting • GlobeNewswire Inc. • 04/05/2024 08:30:00 PM
- Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 03/29/2024 12:30:00 PM
- Elicio Therapeutics Announces $6.0 Million Private Placement Financing • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/05/2024 01:30:00 PM
- Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors • GlobeNewswire Inc. • 01/25/2024 02:00:00 PM
- Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium • GlobeNewswire Inc. • 01/17/2024 01:30:00 PM
- Elicio Therapeutics to Present at the B. Riley Securities 4th Annual Oncology Conference • GlobeNewswire Inc. • 01/16/2024 01:30:00 PM
- Elicio Therapeutics Announces First Patient Dosed in Randomized Phase 2 Pancreatic Cancer Study • GlobeNewswire Inc. • 01/11/2024 01:30:00 PM
- Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002 • GlobeNewswire Inc. • 01/09/2024 11:00:00 AM
- Elicio Therapeutics Announces $7.0 Million Private Placement Financing • GlobeNewswire Inc. • 12/22/2023 02:00:32 PM
- Elicio Therapeutics to Present at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference • GlobeNewswire Inc. • 12/04/2023 01:00:00 PM
- Elicio Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 11/09/2023 09:30:00 PM
- Elicio Therapeutics Presents Updated Preliminary Immunogenicity Data from the Ongoing Phase 1 Study of ELI-002 and New Preclinical Data on ELI-007 and ELI-008 at the Society for Immunotherapy of Cancer (SITC 2023) Annual Meeting • GlobeNewswire Inc. • 11/03/2023 08:30:00 PM
- Elicio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer’s (SITC 2023) Annual Meeting • GlobeNewswire Inc. • 10/11/2023 12:00:00 PM
- Elicio Therapeutics Presents Updated Preliminary Data Including Promising Relapse-Free Survival Data from the Phase 1 Study of ELI-002 at AACR Special Conference: Pancreatic Cancer • GlobeNewswire Inc. • 09/27/2023 09:30:00 PM
- Elicio Therapeutics Receives $2.6 Million Grant from the Gastro-Intestinal (GI) Research Foundation to Fund Research for Two Therapeutic Cancer Vaccines • GlobeNewswire Inc. • 09/07/2023 12:00:00 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM